Aclarion (ACON) EBITDA Margin (2021 - 2026)
Aclarion's (ACON) quarterly EBITDA Margin came in at 11503.18% in Q2 2026, down 251458.0% on a YoY basis from N/an in Q2 2025, and up 18.59% quarter-over-quarter from 14129.33% in Q1 2026.
Powered by 
Analysis
Aclarion (ACON) EBITDA Margin (2021 - 2026) Analysis & Trends
Aclarion (ACON) has reported EBITDA Margin for 6 consecutive years, with 11503.18% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin fell 251458.0% year-over-year to 11503.18%; the trailing twelve-month figure through Jun 2026 stood at 11592.14% (down 153541.0% YoY), and the FY2025 full-year result was 9312.55%, up 274468.0% from the prior year.
- EBITDA Margin climbed to 11503.18% in Q2 2026 per ACON's latest filing, from 14129.33% in the prior quarter.
- Across five years, EBITDA Margin topped out at 4184.99% in Q4 2022 and bottomed at 20726.38% in Q2 2022.
- Historically, EBITDA Margin has averaged 10117.24% across 5 years, with a median of 8991.97% in 2024.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin sank 1828054 bps in 2022, then soared 1248950 bps in 2023.
- Over 5 years, EBITDA Margin stood at 4184.99% in 2022, then sank by 95 bps to 8163.67% in 2023, then tumbled by 116 bps to 17652.66% in 2024, then surged by 39 bps to 10785.18% in 2025, then slipped by 7 bps to 11503.18% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 11503.18%, 14129.33%, and 10785.18% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 44.53 Bn | 37.29 Bn | 695.95 Mn | 29.64% |
| 2 | Waystar Holding | 4.81 Bn | 4.62 Bn | 221.99 Mn | 25.98% |
| 3 | Doximity | 4.74 Bn | 4.05 Bn | 132.93 Mn | 21.48% |
| 4 | CCC Intelligent Solutions Holdings | 4.41 Bn | 4.30 Bn | 210.64 Mn | 21.52% |
| 5 | EverCommerce | 1.40 Bn | 1.27 Bn | 119.50 Mn | 11.89% |
| 6 | Schrodinger | 1.32 Bn | 904.47 Mn | 32.43 Mn | -70.55% |
| 7 | Certara | 1.21 Bn | 1.03 Bn | 58.15 Mn | -0.21% |
| 8 | GoodRx Holdings | 1.18 Bn | 887.53 Mn | 179.41 Mn | 11.79% |
| 9 | Healthstream | 853.81 Mn | 787.08 Mn | 54.72 Mn | 9.94% |
| 10 | Aclarion | 5.79 Mn | 5.79 Mn | 8,297.00 | -11,503.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11,503.18% |
| Mar 31, 2026 | -14,129.33% |
| Dec 31, 2025 | -10,785.18% |
| Sep 30, 2025 | -9,666.16% |
| Jun 30, 2025 | -8,988.60% |
| Mar 31, 2025 | -7,855.96% |
| Dec 31, 2024 | -17,652.66% |
| Sep 30, 2024 | -8,995.34% |
| Jun 30, 2024 | -10,350.57% |
| Mar 31, 2024 | -12,609.32% |
| Dec 31, 2023 | -8,163.67% |
| Sep 30, 2023 | -6,095.86% |
| Jun 30, 2023 | -8,236.88% |
| Mar 31, 2023 | -4,637.86% |
| Dec 31, 2022 | -4,184.99% |
| Sep 30, 2022 | -8,963.12% |
| Jun 30, 2022 | -20,726.38% |
| Mar 31, 2022 | -8,565.26% |
| Dec 31, 2021 | -8,922.25% |
| Sep 30, 2021 | -7,337.83% |